Introduction
PLS is a rare, inherited, autosomal-recessive disease, characterized by diffuse palmoplantar keratosis and a severe prepubertal periodontitis, leading to an edentulous state in adolescence [1] . Chronic periodontitis is a disorder initiated by dysbiosis within the oral plaque biofilm. It progresses as a result of an abnormal host inflammatory-immune response, characterized by exaggerated and nonresolving chronic inflammation, and leads to periodontal tissue damage and bone loss [2] . PLS has an estimated prevalence of 1-4 cases per million with signs and symptoms appearing between 1 and 4 yr of age, typically resulting in permanent tooth loss during adolescence. There is no predominant racial or sexual predilection; however, one third of reported cases involve parental consanguinity [3] . It is noteworthy that systemic immunodeficiency in PLS is relatively mild, with 15-20% predisposed to recurrent infections [4] , yet the local periodontitis is profoundly aggressive.
PLS is caused by mutations in the gene encoding the lysosomal CTSC (CTSC gene); .50 mutations in the gene have been reported as responsible for PLS, with phenotypes ranging from specific loss of function (resulting in a deficiency) to complete absence of the enzyme. CTSC is expressed in high levels in neutrophils and is responsible for the activation of NSPs. The loss of CTSC activity causes the subsequent cessation of NSP activity [5, 6] . Failure of NSPs to eliminate periodontal bacteria is thought to be the underlying cause of the severe periodontal disease in patients with PLS; however, comprehensive and systematic characterization of neutrophil function in PLS has been hampered by the rarity of the disease and case studies limited to individual patients.
Neutrophils represent the first line of defense against microbial pathogens. Neutrophils resolutely survey tissues for microorganisms, and during tissue infections, they extravasate the circulation into the tissues, where they undergo directional movement toward the source of infection via chemical gradients (chemotaxis). This highly regulated recruitment process is orchestrated by the release of chemoattractants that may be host derived, such as IL-8 and MIP-1a, or pathogen derived (e.g., fMLP). Neutrophils function by eradicating pathogens via phagocytosis and subsequent intracellular and extracellular killing mechanisms in situ as a vital part of innate and acquired immunity.
Phagocytosis involves pathogen internalization and destruction via reactive ROS generation following the assembly of NADPH oxidase at the phagosome membrane, the fusion of 4 distinct types of neutrophil granules (azurophilic/primary, specific/ secondary, gelatinase/tertiary, and secretory), and release of AMPs into the phagosome. The azurophilic granules contain several microbicidal agents, including MPO, defensins, and various NSPs that include NE, CG, PR3 [5] , and the recently described NSP4 [7] .
NSPs can be released extracellularly following limited granule exocytosis [8] , binding to the external cell surface, where they target a variety of host chemokines, cytokines, growth factors, and cell-surface receptors contributing to pro-and anti-inflammatory processes. PR3 has been shown to cleave active IL-8, increasing its potency [9] , and to splice the inactive membrane-bound proform of TNF-a [10] , resulting in activation. Conversely, NSP processing affects the activity of chemokines, such as MIP-1a [11] and IL-8 [12] , resulting in their inactivation. In addition, NSPs have been shown to inactivate IL-6 at inflammatory sites [13] ; thus, NSPs appear to play a key role in orchestrating immunostimulatory signals.
One recently described neutrophil-mediated, antimicrobial strategy involves the production of NETs, which comprise decondensed nuclear chromatin associated with granule-derived antimicrobial proteins, including NSPs [14] . The proposed role of NETs is to facilitate neutrophil containment and destruction of pathogenic organisms, although the mechanisms that lead to NET formation are not completely understood. NE and ROS have been shown to be fundamental to NET release [15] . In addition, the specific granule-derived AMP cathelicidin [human cathelicidin 18 (hCAP18)/LL-37] is cleaved by PR3, forming LL-37, which is also known to facilitate NET formation [16] .
For decades the consensus has been that patients with PLS suffer a severe prepubertal periodontitis as a result of NSP deficiencies failing to eliminate causative pathogens, in particular, A. actino [17] . However, such proposed mechanisms fail to explain the severe periodontal inflammation, associated alveolar bone destruction, and subsequent tooth loss that characterizes PLS periodontitis. This relates, in part, to a lack of systematic evaluation of different aspects of neutrophil function, which given the diverse range of NSP-dependent processes that in turn require CTSC activity, are likely to reveal a more complex series of linked events that culminate in the destructive, localized, chronic periodontal inflammation that characterizes PLS. Moreover, in the last decade, it has become clear that neutrophils are not merely short-lived destructor cells, armed with a prepackaged cytotoxic arsenal, but in fact, survive for 5.4 d in the circulation [18] and are capable of more subtle synthetic activities, elaborating various signaling molecules, including proinflammatory cytokines [19] and MRPs; of note are the calcium-binding proteins S100A8 and S100A9, which represent ;45% of proteins within the neutrophil cytosol [20] . S100s, also known as calgranulins, are involved in many proinflammatory immune processes, including phagocyte migration, chemotaxis, and antimicrobial defense.
Aims
In this study, we aimed to characterize comprehensively peripheral blood neutrophil function from a group of patients with PLS (aged between 9 and 14 yr) for the first time, using novel assays of directional chemotactic accuracy, NET formation, ROS, and cytokine release to explain the likely mechanisms underpinning the local, severe periodontal inflammation in the absence of significant systemic immune dysfunction in PLS.
MATERIALS AND METHODS

Blood collection and neutrophil isolation
Whole blood (up to 18 ml) was collected from 5 adolescents from 5 different families with PLS at Birmingham Children's Hospital and 5 gender-matched control subjects. Exclusion criteria included smoking and pregnancy. Ethical approval was provided by the West Midlands/The Black Country National Research Ethics Service Committee (14/WM/1175).
Gender-matched, young, healthy control subjects (aged 19-21 yr) were recruited from students within the University of Birmingham Dental School. Neutrophils were isolated by Percoll density centrifugation using 2 discontinuous gradients-1.079 and 1.098-followed by erythrocyte lysis (0.83% NH 4 Cl containing 1% KHCO 3 , 0.04% EDTA, and 0.25% BSA), as previously described [21] . Cells were resuspended in gPBS (1 mM glucose) and cations (1 mM MgCl 2 , 1.5 mM CaCl 2 ). The cells were diluted accordingly. Cell viability was determined by Trypan blue dye exclusion (typically, .98%) and cell purity by cytospin. Plasma was also prepared by centrifugation and stored at 280°C before further use. For all subsequent assays, plasma was used neat/ diluted, according to relevant assay manufacturers' instructions. As a result of low neutrophil counts, it was not possible for all 5 patient samples to be used in all assays; the numbers included are specified accordingly.
NET assays
NET DNA was quantified as described previously by our group [22] . In brief, neutrophils were resuspended in RPMI 1640 and added to a preblocked, 96-well microplate (1 3 10 5 in 150 ml/well). NET-bound components were assayed within neutrophil supernatants using the following 96-well microplates: 1) NE, equal volumes (100 ml) of supernatants and 0.5 M N-methoxysuccinyl-Ala-Ala-Pro-Val p-nitroanilide were mixed; after 2 h incubation (37°C), absorbance was measured at 405 nm; 2) NET-bound MPO, equal volumes (50 ml) of supernatant and 3,39,5,59-tetramethylbenzidine substrate solution were mixed and incubated (20 min at room temperature); subsequently, the reaction was stopped by addition of sodium phosphate (50 ml, 1 M), and absorbance was measured at 540 nm; 3) NET-bound CG, equal volumes (50 ml) of supernatant and N-succinyl-Ala-AlaPro-Phe p-nitroanilide were mixed and incubated (2 h, 37°C), after which absorbance was measured at 405 nm.
ECL assay of ROS production
ROS were variously analyzed using the chemiluminescent reagents luminol, isoluminol, and lucigenin to detect total, extracellular ROS, and superoxide production, respectively, as described previously [19, 22] . In brief, a white, 96-well microplate was preblocked by addition of PBS with 1% BSA (200 ml/well) and incubated overnight at 4°C; before use, the liquid was aspirated off. Neutrophils were suspended in gPBS and seeded into the preblocked, 96-well microplate (1 3 10 5 in 100 ml/well). Chemiluminescent reagents were added to the appropriate wells: luminol (30 ml, 3 mM), lucigenin (30 ml, 3 mM), or isoluminol (60 ml, 3 mM), with HRP (15 ml, 6 U). After a 30 min baseline incubation period, selected wells were stimulated with PMA (25 nM) to activate PKC directly without cell-surface receptor ligation or bacterial stimuli (opsonized S. aureus and heat-killed A. actino). All assays were performed at 37°C using a Berthold Technologies microplate luminometer (LB96v).
Chemotaxis assay
The Insall chamber was used for a novel, directional chemotaxis assay [23] . Neutrophils at 1 3 10 6 /ml were suspended in RPMI 1640, and 400 ml was added to 7.5% BSA-coated, acid-washed (0.2 M HCl) coverslips (22 mm) and incubated at room temperature for 20 min. The coverslip was then inverted onto the Insall chamber, and excess fluid was aspirated off. Chemoattractants fMLP (10 nM) and MIP-1a (100 ng/ml) were used along with RPMI 1640 (control). For chemotaxis with MIP-1a, a prior incubation step was included: GM-CSF at 200 pg/ml for 30 min, as is required for MIP-1a receptor upregulation and effective chemotaxis [24] . Each chemoattractant/buffer was injected into the chemoattractant channels and visualized using a Zeiss Primovert microscope (Carl Zeiss Imaging, Thornwood, NY, USA) and images captured every 30 s for up to 40 frames per condition using a QImaging Retiga 2000R camera (QImaging, Surry, BC, Canada). The frames were processed using Q Pro Imaging software (QImaging) and analyzed further using ImageJ 1.45SR software (NIH, Bethesda, MD, USA) using the manual-tracking MTrackJ plug-in. For each condition, 15 cells were tracked, and the data generated were used to calculate speed, velocity, and chemotactic index, as defined previously [25] [26] [27] .
Cell culture
Neutrophils were cultured overnight as described previously [19, 28] . In brief, isolated neutrophils (at 2.5 3 10 6 /ml) were suspended in RPMI 1640, supplemented with 0.3 g/l glutamine, 0.232 g/l HEPES, 100 mg/ml streptomycin, and 10% low endotoxin FCS. Cultures were incubated for 18 h at 37°C and 5% CO 2 , with and without bacterial stimuli as used to measure NETs and ROS (MOI 1 in 100), after which the supernatants were collected and stored at 280°C until further analysis of strategically relevant cytokines, MMP9, NE, LL37, and S100A-8/9.
Multiplex assay of neutrophil cytokine and MMP9 release
Proinflammatory cytokine (IL-1b, IL-6, IL-8, MIP-1a, TNF-a) and MMP9 release were measured using ProcartaPlex multiplex immunoassays (Affymetrix-eBioscience, Santa Clara, CA, USA), according to the manufacturer's instructions.
ELISA of AMPs
NE (eBioscience, San Diego, CA, USA), LL-37 (Hycult Biotech, Plymouth Meeting, Pennsylvania, USA), and S100A-8/9 (R&D Systems, Minneapolis, MN, USA) were quantified from neutrophil cell cultures and plasma samples via ELISA assays, according to the manufacturers' instructions.
Plasma protein oxidation
In addition, plasma protein carbonylation was assayed as a measure of oxidative damage, as described previously [29] . In brief, the protein content of the plasma samples was measured using bicinchoninic acid assay. Oxidized standards (prepared using sodium borohydride) and plasma samples were diluted in carbonate buffer (pH 9.6, 0.05 M) to 20 mg/ml, and 50 ml of each was pipetted in triplicate into a Nunc-Immuno plate (MaxiSorp; Nunc, Roskilde, Denmark). Samples were derivatized directly on the plate using 1 mM dinitrophenylhydrazine in 2 M HCl. 
Statistical analysis
Statistical analyses included (where levels were detectable) the following: NETs, ROS, luminex, and ELISA assays using Mann-Whitney U and KruskalWallis test. Chemotaxis was analyzed by Mann-Whitney U test. Table 1 provides summary patient demographics and cathepsin C gene test mutation analyses.
RESULTS
Quantification of NE and LL-37 from neutrophil culture supernatants and patient plasma NE and LL-37 were quantified in plasma and also from cultured neutrophil supernatants, both unstimulated and following TLR and FcgR stimulation (Fig. 1A-D) , and from plasma. Both proteins are activated by CTSC; NE is activated by CTSC directly, and LL-37 is activated via PR3 [30] , following PR3 activation by CTSC. NE was almost completely absent in both plasma and neutrophil supernatants. LL-37 was absent in plasma from patients with PLS but was present at low concentrations in supernatants following stimulation with heat-killed bacteria or particularly with opsonized S. aureus, suggesting minimal CTSC activity. These results indicate systemic and local NSP deficiency in patients with PLS.
Quantification of NETs and NET-bound components
The ability of patients with PLS to produce NETs was determined by fluorometric quantification of NET DNA and also by colorimetric quantification of the NET-associated proteins, NE, MPO, and CG. NETs and NET-bound proteases were substantially decreased or deficient in patients and significantly lower (where calculated) compared with control subjects for all receptor stimulations evaluated ( Fig. 2A-D) . The absence of, or marked reduction in, NETs produced was confirmed by epifluorescence microscopy (Fig. 2E) , providing additional data to that recently reported in a single patient with PLS [31] . The reduced presence of NET-bound MPO further supports the lack of NET structures in these patients, who do not otherwise suffer a MPO deficiency. NE and CG, which are both activated by CTSC, were also extremely low in patients with PLS.
Neutrophil ROS generation and plasma protein oxidation in PLS
Total and intracellular ROS and superoxide were detected using different chemiluminescent reagents-luminol, isoluminol, and lucigenin, respectively (Fig. 3A-C) . In all conditions, ROS generation was the same or higher in patients with PLS compared with control subjects; statistical significance was reached with the use of PMA. Protein carbonylation, a ROSinduced marker of oxidative stress, was also measured in plasma to provide evidence of ROS hyper-responsivity ex vivo (Fig. 3D) . These results add to previous work demonstrating decreased antioxidant defenses/increased oxidative stress (lipid hydroperoxide levels) in unstimulated neutrophils from patients with PLS [32] .
Cytokine, MMP9, and S100A8/9 levels in plasma and neutrophil culture supernatants
The proinflammatory cytokines IL-1b, IL-6, IL-8, MIP-1a, and TNF-a were quantified from culture supernatants and plasma samples by multiplex assay. In addition, MMP9, the major enzyme released by neutrophils involved in the breakdown of the ECM to facilitate movement through the tissues, and the MRPs S100A8 and -A9 were quantified by ELISA. Figure 4A -H (Supplemental Table 1 ) shows neutrophil culture supernatant levels, and Table 2 shows plasma concentrations. Within cultured neutrophil supernatants, there was a significant increase in IL-6, IL-8, and MIP-1a (P , 0. 0286), in the absence of stimulation, indicating a hyperactive neutrophil phenotype. Following TLR stimulation, cytokines IL-6, IL-8, MIP-1a, and TNF-a were all higher in PLS than control subjects (P = 0. 0286). In addition, S100A9 was found to be elevated. The same results were achieved with FcgR stimulation, with the exception of IL-6. The neutrophil supernatant results demonstrate that PLS neutrophils exhibit a hyper-reactive neutrophil phenotype. IL-8 and MMP9 levels were higher in PLS plasma than control subjects, consistent with neutrophil cell-culture supernatant data.
Neutrophil chemotaxis in PLS
Neutrophil directional chemotactic accuracy was measured in PLS using the Insall chamber. Speed (overall cell movement), velocity (movement in the direction of the chemoattractant source), and chemotactic index (a measure of the accuracy of cell orientation) were measured over time in the presence of buffer or chemoattractant. Speed was significantly lower in patients when exposed to MIP-1a (Fig. 5A) , a trend that was consistent for MIP-1a and fMLP when velocity (Fig. 5B ) and chemotactic index (Fig. 5C) were measured. Figure 5D shows the cell paths of all tracked cells per condition, illustrating the differences in the course of the cell movements. MIP-1a is a target for NSPs, which deactivate MIP-1a. As NSP function is lost in individuals with PLS, MIP-1a was used in the chemotaxis assays All volunteers had severe prepubertal periodontitis. Mutation analysis was by direct sequencing. Patient 1 was a compound heterozygote and had the mildest clinical phenotype but also had a very low neutrophil count at the time of venepuncture and thus was used for the NET quantification assay only. Patient 2 had a Y294C mutation (maternal allele) and thus is heterozygous for this mutation. The paternal allele was not detected and is probably within the intronic region that was not subject to analyses. BMI, body mass index; ND, not detected; N/A, not applicable.
to ascertain whether neutrophils of patients with PLS chemotax differently from those of healthy control subjects and whether MIP-1a chemotaxis is at all enhanced in patients with PLS over control subjects. Neutrophils in patients with PLS showed significantly reduced speed, velocity, and chemotactic accuracy compared with those of control subjects in response to MIP-1a and also a lower chemotactic index (accuracy of movement) in response to fMLP.
DISCUSSION
This is, to our knowledge, the most comprehensive analysis of neutrophil function in patients with PLS compared with unaffected control subjects and the first to explore directional chemotaxis and cytokine release as part of the neutrophil repertoire. PLS neutrophils demonstrated negligible NET formation, as analyzed by assays of NET DNA, and an almost total absence of the NET-associated AMPs CG, NE, and MPO, despite the fact that PLS neutrophils are not MPO deficient, as previously reported [33] . NE and CG are both enzymes that are activated by CTSC, and in vitro studies of NSPs have demonstrated that CG and NE are able to kill A. actino in addition to other periodontal bacteria [34] , and so their deficiency likely compromises neutrophil antimicrobial efficacy, allowing for the persistence of some pathogenic species over others in PLS. NE is necessary for NETosis, as demonstrated by the study of NE disorders, such as ELA2-related neutropenia, where NE activity is deficient [35] , and NET formation is diminished. Conversely, in HAX1-related neutropenia, elastase is functional, and patients with HAX1 neutropenia produce NETs [36] .
The ROS data indicate an enhanced response to PMA in PLS, consistent with a hyper-reactive neutrophil phenotype [21] that may contribute significantly to the oxidative stress (elevated lipid hydroperoxide levels) and antioxidant compromise, reported previously in PLS [22] . The increased ROS detected in neutrophils of patients with PLS may contribute to host-mediated periodontal tissue damage at sites where neutrophils are the dominant immune cell, such as the periodontium.
Cytokine measurements demonstrated neutrophil hyperactivity in PLS, with increased release of proinflammatory cytokines (IL-6, IL-8, and MIP-1a) from unstimulated cells. This was supported further by elevated cytokine levels in patients' 1000) . These stimuli trigger NET formation in different ways; HOCl is the downstream ROS required for NET release and whose exogenous addition bypasses NADPH oxidase activation. PMA crosses the cell membrane and directly activates PKC, allowing for NET release. TLR stimulation, using heat-killed bacteria, was also used. Bacteria were selected for each assay on the basis of clinical relevance, in that they are implicated in PLS (continued on next page) plasma relative to control subjects. In addition, MMP9 levels were elevated in the plasma of patients with PLS. Furthermore, hyper-reactivity (to a stimulus), in terms of proinflammatory cytokine release and also S100A9 concentration, was also evident from the supernatants of stimulated cultured neutrophils. Higher S100A8/9 concentrations have been reported in inflamed tissues and are known to be markers of neutrophil activation [37] . Interestingly S100A9 is a target for CG [38] to generate NIF, which has been shown to inhibit neutrophil migration and chemotaxis in vitro [39] . The action of NIF may represent 1 means of limiting the neutrophil influx into inflammatory lesions, and its absence may contribute to the nonresolving, destructive, local inflammation evident in PLS. Conversely, higher levels of S100A9 in PLS, which can form a heterodimer with S100A8, have been shown to be involved in the assembly of the NADPH oxidase complex [40] , which may explain the heightened ROS levels in our PLS studies. Neutrophil chemotaxis was shown to be defective in patients with PLS, potentially increasing neutrophil tissue transit times and further potentiating neutrophil-mediated tissue damage. NSPs de-activate MIP-1a and IL-8, and the loss of NSP function in PLS may result in relentless neutrophil recruitment to periodontal tissues by such chemokines. Neutrophil speed and 100) . Three different stimulation pathways were assayed: FcgR (using opsonized S. aureus), TLR (F. nucleatum), and direct receptor-independent stimulation of PKC by PMA. ROS production was measured for (A) total ROS (detected by luminol; n = 4), (B) extracellular ROS (isoluminol; n = 4), and (C) superoxide (lucigenin; n = 4) release. ROS release for patients was higher than control subjects, with significance with PMA for all 3 chemiluminescent substrates. (D) Plasma protein carbonylation, a measure of oxidative stress, was measured by anti-DNP ELISA (n = 5). Circles are as in Fig. 1 velocity were also reduced in response to MIP-1a relative to control subjects, and there was a significant difference in directional chemotactic accuracy of PLS neutrophils for MIP-1a and fMLP. Previous studies that identified impaired chemotaxis in PLS were performed using different assays to those presented in this study, such as the Boyden chamber [41] and the zymosanactivated serum assay [42] . The latter assays do not measure directional chemotaxis, unlike the direct visualization chamber used in our study. Indeed real-time observation of migrating cells by time-lapse video microscopy is considered the "gold standard" for investigating chemotaxis [43] .
Taken together, the data generated in this study point to 2 key scenarios as mechanistic explanations for PLS periodontitis, which will be discussed in turn: 1) relentless recruitment of neutrophils into periodontal tissues, where tissue transit times are increased, and 2) compromised antimicrobial killing.
Relentless recruitment of hyperactive/reactive neutrophils into periodontal tissues
The importance of NSPs in the antimicrobial functionality of neutrophils and the implications of NSP deficiency for the development of periodontitis have been reported previously [4, 17] . In addition, neutrophils lacking NE and CG were unable to undergo cytoskeletal reorganization, despite adhering to immune complex-coated surfaces in vitro [44] , the underlying cause being a decrease in the phosphorylation of the GTPase RAC1, which is performed indirectly by CG. Therefore, the lack of NSPs in PLS may be an underlying cause of the chemotactic defect reported here. Moreover, MIP-1a isoforms are inactivated by NSPs [11] , and MIP-1a has been shown to act as an osteoclast activation factor, inducing bone resorption [45] . Thus, we propose that the constant presence of active MIP-1a and failure to generate NIF (not reported here) in PLS may drive a relentless recruitment and accumulation of activated neutrophils to the inflamed periodontal tissues and lead to the subsequent destruction of periodontal connective tissue and alveolar bone evident in patients with PLS. Such a homeostatic imbalance would not manifest systemically as a result of the absence of a constant microbial challenge, such as is present in the periodontal tissues. In addition, the deficiency of LL-37, itself a result of PR3 deficiency in patients with PLS, increases the incidence of microbial infection, notably with the periodontal pathogen A. actino [33] . NSP dysfunction is associated with periodontal disease in other syndromes, including Chediak Higashi syndrome [46] and the allelic variant to PLS, Haim Munk syndrome [47] . Furthermore, neutrophils from sufferers of specific granule deficiency, characterized by defects in the packaging of azurophil and specific granules (which contain NSPs and NADPH oxidase components, respectively), have been shown to exhibit decreased phagocytosis, diminished ROS formation, and reduced chemotaxis [48] .
Compromised antimicrobial killing
Patients with PLS suffer modest systemic infections, with 15-20% patients reporting recurrent infections, unlike patients with CGD, characterized by the lack of a functional NADPH oxidase and the subsequent inability to produce ROS or form NETs. It is noteworthy that patients with CGD are not overtly susceptible to periodontitis [49] , suggesting that the periodontal tissue destruction seen in PLS cannot be fully explained by compromised neutrophil antimicrobial defenses. PLS individuals are not systemically immunocompromised, and our reported results demonstrate that PLS neutrophils have the capacity to respond to pathogenic stimuli, thus NSPs do not constitute the primary antimicrobial defense mechanism, and the underlying cause of periodontitis in PLS cannot be explained by reduced neutrophil bacterial killing alone. We propose that the periodontal tissue damage in patients with PLS results from a complex series of events arising downstream of the CTSC deficiency and dependent on a diverse range of NSP functions that are normally active at sites of microbial challenge. Specifically, impaired bacterial killing results in persistence of pathogenic species and triggers the relentless recruitment of hyperactive and reactive neutrophils in terms of ROS and proinflammatory cytokines into the periodontium. The latter, augmented by extended tissue transit times and a failure to de-activate MIP-1a, likely drives the connective tissue damage and bone loss in PLS. Defects in neutrophil function have been shown in several studies of patients with chronic periodontitis; peripheral neutrophils from patients with chronic periodontitis exhibit hyperreactivity with respect to ROS release [21] , proinflammatory cytokine production [19] in response to a microbial challenge, and also hyperactivity in the absence of an exogenous [50] . Chemotaxis in patients with chronic periodontitis has also been found to be defective, with only partial improvement after nonsurgical therapy [27] , and oxidative stress is also a strong feature of periodontitis. In PLS, failure to activate and release NSPs appears to exaggerate the above defects and offers a more plausible explanation for the aggressive periodontal tissue damage seen in PLS than one based purely on defective antimicrobial defenses.
Conclusions
This study has characterized, for the first time, a range of neutrophil behaviors in patients with PLS from 5 different families and provided new insights into the functional consequences of CTSC deficiency upon periodontal tissue destruction and tooth loss. Our results show that PLS neutrophils have a substantially reduced capacity for NET production, with NET visualization data confirmed by the almost-total absence of NET-related proteins CG, NE, and MPO. ROS generation was higher in PLS, and chemotactic speed and velocity to a MIP-1a stimulus were reduced, with defective directional chemotactic accuracy toward fMLP and MIP-1a. Thus, we have demonstrated a range of functional neutrophil defects in PLS, arising secondary to the CTSC deficiency and consequent failure to activate NSPs, the cumulative effects of which may conspire to destroy periodontal tissues. The failure of key neutrophil antimicrobial activities likely maintains a stimulus for a misdirected recruitment of hyper-responsive neutrophils into periodontal tissues and provides a plausible explanation for the severe inflammation and bone loss that characterizes PLS periodontitis. Interestingly, PLS individuals do not suffer systemic infections, other than rarely reported skin abscesses; therefore, the neutrophil defects appear specifically localized to areas of the body susceptible to a direct and chronic bacterial challenge. 
